Established in 1988, the NHMRC Clinical Trials
Centre (CTC) now
has a diverse group of 150 researchers. We have
earned an outstanding reputation for contributing to major advances
in clinical care via our high-quality collaborative
clinical trials research.
Clinical trials research determines how existing drugs and
treatments can be used most effectively and explores
promising new therapies. Trials answer questions such as:
- Is it better for patients with various cancers to have
chemotherapy, radiotherapy, or both?
- How should patients with heart disease be best treated to
reduce the risk of heart attacks or strokes?
- What are the benefits and risks of providing higher or
lower levels of extra oxygen to very premature
The answers to these types of trials questions have led to
important advances in patient care, which have resulted
in better health outcomes for patients globally.
For example, thousands of lives are saved each year as a result
of new cholesterol treatments, and patients are living longer,
better-quality lives as a result of improved therapies for breast,
lung, bowel and other cancers.
Towards the future
We will continue our efforts to make clinical
trials an integral part of health care. We also plan
to maintain and build our global collaborative ties with
other research networks, universities, government, and industry, to
answer important clinical questions in new therapy areas.